Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹1,203.90
Market cap: ₹1,21,141 Cr
Revenue (annual): ₹27,148 Cr
Net profit (annual): ₹5,040 Cr
P/E (TTM): 26.8×Sector 50.4×
Promoter holding: 75.01%+0.01% QoQ
FII holding: 6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Legal & Regulatory 1 Financial Results 1 Credit Rating 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Aug 2026 19:46 IST BSE

Earnings Call

Zydus Lifesciences Earnings Call Transcript: Key Takeaways

Zydus delivered robust FY27 Q1 results driven by strong India-branded formulations and U.S. generic resilience.

Call: Guides 10% growth

Open call summary → Read the filing ↗

11 Aug 2026 13:27 IST BSE

Earnings Call

Zydus Lifesciences Investor Presentation: Key Takeaways

Zydus Lifesciences reported strong Q1 FY27 revenue growth of 22% YoY, driven by robust performance in India and International formulations, despite a decline in PAT and EBITDA margins.

Open call summary → Read the filing ↗